Quality of life and psychosocial challenges in metastatic breast cancer: the need for tailored interventions in Turkiye

dc.contributor.authorBasaran, Gul
dc.contributor.authorKaradurmus, Nuri
dc.contributor.authorBugdayci Basal, Fatma
dc.contributor.authorAroyo, Violet
dc.contributor.authorSavas, Esra
dc.contributor.authorOzturk Saglam, Ozge Fulya
dc.contributor.authorGunay Aslan, Pinar
dc.date.accessioned2025-11-16T19:34:07Z
dc.date.issued2025
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstractMetastatic breast cancer (MBC) patients face numerous psychosocial difficulties, including physical symptoms, psychological distress, and fears of mortality, which heavily impact their quality of life (QoL). This study addresses the need for culturally and regionally tailored psychosocial interventions by integrating insights from semi-structured interviews with selected stakeholders in Turkiye. Utilizing a qualitative research design, interviews were conducted with a patient association representative, psycho-oncologist, and oncologists with psychological expertise. These interviews, guided by literature-driven questions, lasted about three hours each and explored the challenges MBC patients face, the existing support structures, and the dynamics of patient-doctor interactions in Turkiye. Findings reveal that MBC patients experience significant psychological distress and QoL decline due to economic issues, fears of job loss, societal stigma, family dynamics, and limited psychological support. Effective doctor-patient communication, targeted psychological interventions, and comprehensive family support are essential. Experts advocate for a holistic, psycho-oncological approach, addressing both physical and psychological needs, with recommendations for multidisciplinary care, ongoing psychiatric support, and increased awareness. This study highlights the importance of tailored, patient-centered interventions to improve the QoL of MBC patients in Turkiye.
dc.description.sponsorshipPfizer Turkiye
dc.description.sponsorshipThis study was supported by Pfizer Turkiye.
dc.identifier.doi10.1080/20565623.2025.2511462
dc.identifier.issn2056-5623
dc.identifier.issue1
dc.identifier.pmid41020528
dc.identifier.scopus2-s2.0-105018199266
dc.identifier.scopusqualityQ1
dc.identifier.urihttps://doi.org/10.1080/20565623.2025.2511462
dc.identifier.urihttps://hdl.handle.net/20.500.14730/15227
dc.identifier.volume11
dc.identifier.wosWOS:001584981600001
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherTaylor & Francis Ltd
dc.relation.ispartofFuture Science Oa
dc.relation.publicationcategoryDiğer
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WOS_20250302
dc.subjectMetastatic breast cancer
dc.subjectquality of life
dc.subjectpsychosocial challenges
dc.subjecttailored psychological care
dc.subjectmultidisciplinary support
dc.titleQuality of life and psychosocial challenges in metastatic breast cancer: the need for tailored interventions in Turkiye
dc.typeEditorial

Dosyalar